{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:46:16Z","timestamp":1790109976548,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.brainres.2018.07.024","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T02:52:23Z","timestamp":1532659943000},"page":"204-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Role of TGF-\u03b21\/Smad3-mediated fibrosis in drug resistance mechanism of prolactinoma"],"prefix":"10.1016","volume":"1698","author":[{"given":"Bin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2018.07.024_b0005","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGFbeta signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.brainres.2018.07.024_b0010","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11102-010-0237-4","article-title":"Acquired resistance to cabergoline: progression from initially responsive micro to macroprolactinoma","volume":"13","author":"Alberiche Ruano","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/j.brainres.2018.07.024_b0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0014-5793(89)80792-6","article-title":"Synergistic enhancement of type I and III collagen production in cultured fibroblasts by transforming growth factor-beta and ascorbate","volume":"250","author":"Appling","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainres.2018.07.024_b0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1524-475X.2008.00379.x","article-title":"Expression of transforming growth factor beta isoforms and their roles in tendon healing","volume":"16","author":"Chan","year":"2008","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.brainres.2018.07.024_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","article-title":"The epidemiology of prolactinomas","volume":"8","author":"Ciccarelli","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.brainres.2018.07.024_b0030","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1210\/en.2004-1445","article-title":"Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice","volume":"146","author":"Cristina","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.brainres.2018.07.024_b0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.beem.2009.05.008","article-title":"The epidemiology and genetics of pituitary adenomas","volume":"23","author":"Daly","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2018.07.024_b0040","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2018.07.024_b0045","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1210\/jcem.86.11.8054","article-title":"Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy","volume":"86","author":"Di Sarno","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2018.07.024_b0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"10.1016\/j.brainres.2018.07.024_b0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.brainres.2018.07.024_b0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13402-011-0035-7","article-title":"Rapid quantification of myocardial fibrosis: a new macro-based automated analysis","volume":"34","author":"Hadi","year":"2011","journal-title":"Cell Oncol. (Dordr)."},{"key":"10.1016\/j.brainres.2018.07.024_b0065","first-page":"945","article-title":"TGF-beta signaling and its targeting for glioma treatment","volume":"5","author":"Han","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.brainres.2018.07.024_b0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11102-016-0706-5","article-title":"Magnetic resonance elastography detects tumoral consistency in pituitary macroadenomas","volume":"19","author":"Hughes","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.brainres.2018.07.024_b0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/mol.62.1.65","article-title":"SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7","volume":"62","author":"Inman","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2018.07.024_b0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mce.2014.12.024","article-title":"The role of TGF-beta\/Smad signaling in dopamine agonist-resistant prolactinomas","volume":"402","author":"Li","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.brainres.2018.07.024_b0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-010-0261-4","article-title":"Effect of dopaminergic drug treatment on surgical findings in prolactinomas","volume":"14","author":"Menucci","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.brainres.2018.07.024_b0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11102-005-5085-2","article-title":"Pharmacologic resistance in prolactinoma patients","volume":"8","author":"Molitch","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.brainres.2018.07.024_b0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11060-013-1270-8","article-title":"Management of medically refractory prolactinoma","volume":"117","author":"Molitch","year":"2014","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.brainres.2018.07.024_b0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2176\/nmc.42.202","article-title":"Technical considerations of transsphenoidal removal of fibrous pituitary adenomas and evaluation of collagen content and subtype in the adenomas","volume":"42","author":"Naganuma","year":"2002","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"10.1016\/j.brainres.2018.07.024_b0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1148\/radiol.2383042204","article-title":"Pituitary macroadenomas: preoperative evaluation of consistency with diffusion-weighted MR imaging\u2013initial experience","volume":"239","author":"Pierallini","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.brainres.2018.07.024_b0110","first-page":"746","article-title":"TGF-beta and fibrosis in different organs \u2013 molecular pathway imprints","volume":"1792","author":"Pohlers","year":"2009","journal-title":"BBA"},{"key":"10.1016\/j.brainres.2018.07.024_b0115","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1530\/JOE-15-0451","article-title":"The pituitary TGFbeta1 system as a novel target for the treatment of resistant prolactinomas","volume":"228","author":"Recouvreux","year":"2016","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.brainres.2018.07.024_b0120","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1210\/en.2013-1433","article-title":"Sex differences in the pituitary transforming growth factor-beta1 system: studies in a model of resistant prolactinomas","volume":"154","author":"Recouvreux","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.brainres.2018.07.024_b0125","first-page":"1825","article-title":"Transforming growth factor-beta 1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth","volume":"6","author":"Sarkar","year":"1992","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.brainres.2018.07.024_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144630","article-title":"Histochemical detection of collagen fibers by sirius red\/fast green is more sensitive than van Gieson or sirius red alone in normal and inflamed rat colon","volume":"10","author":"Segnani","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2018.07.024_b0135","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2018.07.024_b0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0656","article-title":"Resistance to dopamine agonists in prolactinoma is correlated with reduction of dopamine D2 receptor long isoform mRNA levels","volume":"166","author":"Shimazu","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.brainres.2018.07.024_b0145","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/s-0035-1549005","article-title":"Prediction of consistency of pituitary adenomas by magnetic resonance imaging","volume":"76","author":"Smith","year":"2015","journal-title":"J. Neurol. Surg. B Skull Base"},{"key":"10.1016\/j.brainres.2018.07.024_b0150","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bj2470597","article-title":"Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts","volume":"247","author":"Varga","year":"1987","journal-title":"Biochem. J."},{"key":"10.1016\/j.brainres.2018.07.024_b0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF03347092","article-title":"Resistant prolactinomas","volume":"34","author":"Vasilev","year":"2011","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.brainres.2018.07.024_b0160","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/EJE-12-0236","article-title":"Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients","volume":"167","author":"Vroonen","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.brainres.2018.07.024_b0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/02688690802617046","article-title":"Expression of TGFbeta1 and pituitary adenoma fibrosis","volume":"23","author":"Wang","year":"2009","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.brainres.2018.07.024_b0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11060-008-9647-9","article-title":"Correlation of MMP(1) and TIMP (1) expression with pituitary adenoma fibrosis","volume":"90","author":"Wang","year":"2008","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.brainres.2018.07.024_b0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11060-009-0107-y","article-title":"Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior","volume":"99","author":"Wu","year":"2010","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.brainres.2018.07.024_b0180","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/0006-291X(86)91020-X","article-title":"Type beta transforming growth factor (TGF-beta) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer system","volume":"135","author":"Ying","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2018.07.024_b0185","doi-asserted-by":"crossref","first-page":"18758","DOI":"10.1073\/pnas.0805411105","article-title":"Perturbation of transforming growth factor (TGF)-beta1 association with latent TGF-beta binding protein yields inflammation and tumors","volume":"105","author":"Yoshinaga","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318304086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318304086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T09:27:04Z","timestamp":1537090024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899318304086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":37,"alternative-id":["S0006899318304086"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2018.07.024","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of TGF-\u03b21\/Smad3-mediated fibrosis in drug resistance mechanism of prolactinoma","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2018.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}